The Goodman Group has filed a patent for a hemostatic device that can close a puncture hole in a blood vessel. The device includes a positioning member, a hemostatic agent, a push-out member, a restricting member, and a switching member. The device allows for controlled movement of the hemostatic agent to close the puncture hole. The switching member enables the movement of the push-out member once the positioning member is in the desired position. GlobalData’s report on Goodman Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to GlobalData’s company profile on Goodman Group, customized implants was a key innovation area identified from patents. Goodman Group's grant share as of September 2023 was 14%. Grant share is based on the ratio of number of grants to total number of patents.
Hemostatic device for closing puncture hole in blood vessel
A recently filed patent (Publication Number: US20230293181A1) describes a hemostatic device designed to close puncture holes in blood vessels that extend to the skin. The device includes a positioning member with an extending section and a first engagement section that can be engaged with the opening in the blood vessel. A hemostatic agent is located on the proximal end side of the first engagement section. The device also includes a push-out member that can move the hemostatic agent to the distal end side using a push-out distal end. A restricting member is included to restrict the movement of the push-out member, and a switching member can switch the state of the restricting member between a restricting state and an enabling state. The device is housed in a housing.
In addition to the above features, the hemostatic device may also include a first moving member that can move relatively inside a first movement region with respect to the restricting member. The restricting member includes a limiting section that is disposed in the first movement region when in the restricting state and not disposed in the first movement region when in the enabling state. The switching member can switch the restricting member from the restricting state to the enabling state by switching the limiting section's position in the first movement region.
The first moving member may include a second engagement section that engages with the limiting section when the limiting section is in the first movement region. The limiting section also includes an urging section that urges the limiting section away from engagement with the second engagement section. The switching member can switch the restricting member from the restricting state to the enabling state by switching the engagement state of the limiting section.
The hemostatic device may further include a notification section that can provide notification of a condition based on the relative movement amount of the positioning member with respect to the housing. It may also include a second moving member that can move relatively to the distal end side of the housing based on the relative movement of the positioning member, and the notification section can provide notification based on the movement amount of the second moving member.
Additionally, the device may include a third moving member that can move relatively to the distal end side of the housing based on the relative movement of the positioning member. The third moving member includes a first magnet, and the housing includes a second magnet that faces the first magnet when the switching member enables the restricting member. The housing may also include a third magnet on the distal end side of the second magnet, and the magnetic force between the first and second magnets is greater than the magnetic force between the first and third magnets.
Overall, this patent describes a hemostatic device with various components and mechanisms that work together to close puncture holes in blood vessels, providing a potentially effective solution for medical procedures requiring hemostasis.
To know more about GlobalData’s detailed insights on Goodman Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
